Although oxygen therapy and mechanical ventilation are the treatment methods for patients with ARDS, they can cause hyperoxic lung injury, and the addition of natural pharmaceutical ingredients prevents/treats hyperoxic lung injury by activating the Nrf2 pathway (Table 1). The gene discussed is NFE2L2; the disease is acute respiratory distress syndrome.